// STATE LEGISLATION TRACKER

Louisiana HB 1093 — HEALTH: Creates the Louisiana Board of Naturopathic Medicine

⚖️ MIXED for peptide users 👤 LOW user impact 📜 Status: Unknown

State: Louisiana
Bill: HB 1093
Session: 2026
Filed: 2026-04-01
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

HB1093 appears to create a Louisiana Board of Naturopathic Medicine. Based only on the title, subjects, and lack of recorded actions, it may affect naturopathic clinicians but does not directly address peptides, compounding, telehealth, FDA 503A/503B, controlled substances, or prescription monitoring.

Key Points

No direct peptide language is available from the provided bill record
Could matter if the bill later defines naturopathic prescribing authority
No clear change to compounded peptide access is shown
No telehealth or pharmacy compounding impact is stated
NP scope is not addressed in the available bill details

What to Watch For

✓

Opportunity If the bill defines naturopathic scope broadly, it could clarify who may advise on peptide-related care.

Concern If the board limits naturopathic prescribing or referral authority, peptide access through NDs could narrow.

Note No recorded actions means the bill's procedural status cannot be confirmed from the provided record.

Note Watch for amendments mentioning prescribing, compounding, telehealth, or controlled substances.

Where the Bill Stands

The OpenStates record provided says no actions are recorded, so the bill's current stage is unclear.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws